Marilena Vrana Reflects on A Year of Growth, Gratitude, and Collective Strength
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
”As the year draws to a close, it offers a natural moment to step back and acknowledge the growth, challenges, and progress that have shaped these past months.
Transitions in leadership are rarely seamless, and stepping into this new role mid-year came with a steep learning curve.
Yet through the transition came a clear lesson: leadership isn’t about having all the answers, but about creating the conditions where collaboration, curiosity, and courage can truly thrive.
This year showed again that resilience is built through collective effort.
The challenges we faced became catalysts for reimagining what’s possible, and our achievements became shared wins that strengthened the sense of purpose across the team, our membership, and the broader community of plasma and plasma-derived medicines.
What has truly fueled me throughout the year is the unwavering dedication of the PPTA Europe staff and members.
Your commitment to the mission, your integrity, and your persistence have shaped not only the milestones we reached, but also the “one-team” culture that continues to take root – grounded in trust, transparency, and shared responsibility.
As the year ends, I am deeply grateful for every colleague, partner, and supporter who contributed to this progress.
Thank you for your patience as I found my footing, for the feedback that sharpened our focus, and for the belief in what we’re building together.
In many ways, I’ve grown not just as a leader, but as a listener, a learner, and a teammate.
The year ahead holds promise with new opportunities, renewed momentum, and continued collaboration.
Here’s to building on this foundation together in the coming year, with purpose and optimism.”
Stay updated with Hemostasis Today.
-
Jul 26, 2026, 07:40Maha Othman: Leading Scientific Collaboration Across Hemostasis at ISTH 2026
-
Jul 26, 2026, 07:20Pablo Corral: Why Should Dyslipidemia Be Any Different?
-
Jul 26, 2026, 06:46Marios Georgakis: Largest GWAS of Transient Ischemic Attacks Reveals New Genetic Insights into Stroke Risk
-
Jul 26, 2026, 06:40Aaron Iding: From Virtual Meetings to Meaningful Connections at ISTH 2026
-
Jul 26, 2026, 06:36How Stroke Services Have Evolved Over the Past 8 Years in Kazakhstan – International Journal of Stroke
-
Jul 26, 2026, 06:31Leonardo Roever: Non-LDL Biomarkers and The Potential Future Applications for 2ry Stroke Prevention
-
Jul 26, 2026, 06:27Chiara Terzo: New Insights into Haemodialysis in Haemophilia B
-
Jul 26, 2026, 06:20Abdul Hanan: Why Do Patients with Immune TTP Behave Differently ?
-
Jul 26, 2026, 04:56Abdul Mannan: Postpartum Bleeding Is Not Always Obstetric Bleeding